RareSearch logo

London Genetics

50+ personnel
Headquartered in Chandler
Established in 2025
Website
Katherine Blick profile

Katherine Blick

🇫🇷 France

5.8

    Reviewed:

  • - Biostatistical Design
  • - 6 weeks February - March 2024
  • - Research Institution

Biostatistical analysis lacked depth, missed key insights.

The biostatistical analysis provided was not as thorough as we had hoped. Some key insights were missed, and we had to engage another provider to get the level of detail we needed. The team seemed overworked and under-resourced.

Abel Crist profile

Abel Crist

🇫🇷 France

8.9

    Reviewed:

  • - Stability Studies
  • - 18 months January 2023 - June 2024
  • - Pharmaceutical Company

Accurate and reliable stability studies, clear reporting.

The stability studies were conducted with precision, and the reporting was clear and thorough. The results provided us with the necessary data to proceed with our regulatory submissions confidently.

Wayne Quigley profile

Wayne Quigley

🇪🇸 Spain

5.4

    Reviewed:

  • - Process Development
  • - 14 weeks June - September 2024
  • - Biotech Company

Process development project faced delays, communication issues.

The process development project encountered multiple delays, and communication was inconsistent. We had to extend our project timeline due to the setbacks, and this impacted our overall production schedule. The team was capable but seemed overextended.

Elsie Effertz Sr. profile

Elsie Effertz Sr.

🇹🇷 Turkey

5.6

    Reviewed:

  • - Clinical Data Management
  • - 8 weeks December 2023 - February 2024
  • - Biotech Company

Delayed delivery and lack of communication during the project.

The data management services were delayed, and communication from the team was lacking. It was difficult to get updates, and when the deliverables arrived, they were not as polished as expected. The delays impacted our project timeline significantly.

Hope Wunsch profile

Hope Wunsch

🇳🇱 Netherlands

8.8

    Reviewed:

  • - Companion Diagnostics Development
  • - 16 weeks January - May 2024
  • - Pharmaceutical Company

High-quality companion diagnostics development, delivered on time.

The development of companion diagnostics was of high quality, and the project was delivered on time. The team's technical expertise and understanding of the regulatory environment were key to the success of the project.